INmune Bio Says Study Shows Drug Candidate Reduced Alzheimer's-Related Brain Changes After Brain Injury

MT Newswires Live

07/15

INmune Bio (INMB) said Wednesday that a peer-reviewed preclinical study published in the Journal of Neurotrauma found its lead drug candidate, XPro1595, reduced Alzheimer's-related brain changes after traumatic brain injury in mice.

The Department of Defense-funded study found that brain injury increased inflammation and amyloid beta levels, both linked to Alzheimer's disease, it said. Treatment with XPro1595 prevented the rise in amyloid pathology and improved memory and pain outcomes, it added.

The company said the findings support further development of XPro1595 for neuroinflammation-driven Alzheimer's disease.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2651245045"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2651245045\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2651245045?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-15 19:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2651245045","market":"sh","top_or_hot":-1,"title":"INmune Bio Says Study Shows Drug Candidate Reduced Alzheimer's-Related Brain Changes After Brain Injury","media":"MT Newswires Live","content":"<html><body><p> INmune Bio (INMB) said Wednesday that a peer-reviewed preclinical study published in the Journal of Neurotrauma found its lead drug candidate, XPro1595, reduced Alzheimer's-related brain changes after traumatic brain injury in mice.</p><p>The Department of Defense-funded study found that brain injury increased inflammation and amyloid beta levels, both linked to Alzheimer's disease, it said. Treatment with XPro1595 prevented the rise in amyloid pathology and improved memory and pain outcomes, it added.</p><p>The company said the findings support further development of XPro1595 for neuroinflammation-driven Alzheimer's disease.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>INmune Bio Says Study Shows Drug Candidate Reduced Alzheimer's-Related Brain Changes After Brain Injury</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nINmune Bio Says Study Shows Drug Candidate Reduced Alzheimer's-Related Brain Changes After Brain Injury\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-07-15 19:50</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> INmune Bio (INMB) said Wednesday that a peer-reviewed preclinical study published in the Journal of Neurotrauma found its lead drug candidate, XPro1595, reduced Alzheimer's-related brain changes after traumatic brain injury in mice.</p><p>The Department of Defense-funded study found that brain injury increased inflammation and amyloid beta levels, both linked to Alzheimer's disease, it said. Treatment with XPro1595 prevented the rise in amyloid pathology and improved memory and pain outcomes, it added.</p><p>The company said the findings support further development of XPro1595 for neuroinflammation-driven Alzheimer's disease.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INMB","symbol_name":"INmune Bio Inc","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2651245045","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2651245045","pubTimestamp":1784116235,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"INmune Bio  said Wednesday that a peer-reviewed preclinical study published in the Journal of Neurotrauma found its lead drug candidate, XPro1595, reduced Alzheimer's-related brain changes after traumatic brain injury in mice.The Department of Defense-funded study found that brain injury increased inflammation and amyloid beta levels, both linked to Alzheimer's disease, it said. Treatment with XPro1595 prevented the rise in amyloid pathology and improved memory and pain outcomes, it added.The company said the findings support further development of XPro1595 for neuroinflammation-driven Alzheimer's disease.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"INMB":"INmune Bio Inc","BK4139":"生物科技"},"translate_title":"INmune Bio 表示研究表明候选药物可减少脑损伤后阿尔茨海默氏症相关的大脑变化","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INMB":1},"content_text":"INmune Bio (INMB) said Wednesday that a peer-reviewed preclinical study published in the Journal of Neurotrauma found its lead drug candidate, XPro1595, reduced Alzheimer's-related brain changes after traumatic brain injury in mice.The Department of Defense-funded study found that brain injury increased inflammation and amyloid beta levels, both linked to Alzheimer's disease, it said. Treatment with XPro1595 prevented the rise in amyloid pathology and improved memory and pain outcomes, it added.The company said the findings support further development of XPro1595 for neuroinflammation-driven Alzheimer's disease.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}